Treatment of Patients With Anxiety Disorder (0777-022)

Clinical trial NCT00539578 · COMPLETED

Trial details

NCT number: NCT00539578
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2002-09-01
Primary completion: 2003-02-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.